focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

Fri, 07th Sep 2018 09:33

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS BURBERRY GROUP TO 'NEUTRAL' ('CONVICTION BUY LIST') - TARGET 2536 PENCE----------RBC RAISES BURBERRY GROUP PRICE TARGET TO 1875 (1750) PENCE - 'UNDERPERFORM'----------RBC INITIATES DCC WITH 'OUTPERFORM' - TARGET 9500 PENCE----------RBC CUTS BUNZL PRICE TARGET TO 1800 (1950) PENCE - 'UNDERPERFORM'----------BERENBERG CUTS SHIRE TO 'HOLD' ('BUY') - TARGET 5000 (4500) PENCE----------JPMORGAN RAISES MELROSE INDUSTRIES PRICE TARGET TO 285 (260) PENCE - 'OVERWEIGHT'----------REDBURN CUTS HSBC TO 'SELL' ('NEUTRAL')----------BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1456 (1387) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 696 (693) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES PRUDENTIAL PRICE TARGET TO 2163 (2076) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES LEGAL & GENERAL GROUP PRICE TARGET TO 317 (311) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES DIRECT LINE PRICE TARGET TO 366 (361) PENCE - 'EQUAL WEIGHT'----------BARCLAYS RAISES AVIVA PRICE TARGET TO 610 (581) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES ADMIRAL GROUP PRICE TARGET TO 1997 (1939) PENCE - 'UNDERWEIGHT'----------HSBC RAISES CENTRICA PRICE TARGET TO 142 (130) PENCE - 'REDUCE'----------KEPLER CHEUVREUX RAISES ASTRAZENECA PRICE TARGET TO 6100 (5630) PENCE - 'BUY'----------JEFFERIES CUTS ASTRAZENECA PRICE TARGET TO 5975 (6200) PENCE - 'HOLD'----------JEFFERIES CUTS GLAXOSMITHKLINE PRICE TARGET TO 1725 (1775) PENCE - 'BUY'----------FTSE 250----------JPMORGAN CUTS GO-AHEAD GROUP PRICE TARGET TO 1420 (1421) PENCE - 'UNDERWEIGHT'----------JPMORGAN CUTS WEIR GROUP PRICE TARGET TO 2060 (2200) PENCE - 'OVERWEIGHT'----------BARCLAYS CUTS WEIR GROUP PRICE TARGET TO 2500 (2600) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES PHOENIX GROUP PRICE TARGET TO 688 (667) PENCE - 'UNDERWEIGHT'----------BARCLAYS RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 693 (667) PENCE - 'EQUAL WEIGHT'----------BARCLAYS RAISES JARDINE LLOYD THOMPSON PRICE TARGET TO 1523 (1495) PENCE - 'OVERWEIGHT'----------BARCLAYS RAISES HISCOX PRICE TARGET TO 1427 (1314) PENCE - 'UNDERWEIGHT'----------BARCLAYS RAISES HASTINGS GROUP PRICE TARGET TO 272 (267) PENCE - 'EQUAL WEIGHT'----------PEEL HUNT RAISES GREENE KING TO 'BUY' ('ADD') - TARGET 700 PENCE----------KEPLER CHEUVREUX RAISES GENUS PRICE TARGET TO 2540 (2470) PENCE - 'HOLD'----------CREDIT SUISSE CUTS WILLIAM HILL PRICE TARGET TO 330 (340) PENCE - 'OUTPERFORM'----------HSBC CUTS WILLIAM HILL PRICE TARGET TO 290 (325) PENCE - 'HOLD'----------OTHER MAIN MARKET AND AIM----------BERENBERG INITIATES GLOBALDATA WITH 'BUY' - TARGET 820 PENCE----------JPMORGAN RAISES REDDE PRICE TARGET TO 207 (197) PENCE - 'OVERWEIGHT'----------PEEL HUNT RESUMES CHEMRING GROUP WITH 'ADD' - TARGET 240 PENCE----------PEEL HUNT RESUMES PAN AFRICAN RESOURCES WITH 'BUY' - TARGET 16 PENCE----------LIBERUM PUTS EI GROUP RATING UNDER REVIEW FROM 'HOLD'----------

More News
24 Aug 2018 11:54

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a

Read more
24 Aug 2018 10:39

WINNERS & LOSERS SUMMARY: Shire Rises As US FDA Approves Takhzyro Drug

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 2.6%. The Irish pharmaceutical company said a

Read more
24 Aug 2018 08:38

LONDON MARKET OPEN: Stocks Mixed, Shire Rises After Drug Approval

LONDON (Alliance News) - Stock prices in London were mixed early Friday, as markets await US Federal Reserve Chair Jerome Powell's speech in Wyoming later in the day. In the large cap index rose

Read more
24 Aug 2018 08:06

FDA gives nod to Shire's TAKHZYRO treatment

(Sharecast News) - Shire announced on Friday that, following priority review, the US Food and Drug Administration (FDA) has approved the 'TAKHZYRO' (lanadelumab-flyo) injection for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years of age and older.

Read more
24 Aug 2018 07:41

LONDON MARKET PRE-OPEN: Slightly Lower Call Ahead Of Powell Speech

LONDON (Alliance News) - Stock prices in London are seen lower on Friday ahead of US Federal Reserve Chair Jerome Powell's speech later during the day, while in a quiet day for UK company news In

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 09:21

Shire Partner Shionogi Files New Drug Application For Intuniv In Japan

LONDON (Alliance News) - Irish drugmaker Shire PLC said on Monday its Japanese partner Shionogi & Co Ltd has submitted a new drug application for the manufacture and marketing of Intuniv in is

Read more
13 Aug 2018 07:51

Shire and Shionogi apply to expand ADHD treatment to adults

(Sharecast News) - Shire and Shionogi have applied to expand the use in Japan of co-developed drug Intuniv to treat adults for attention deficit hyperactivity disorder.

Read more
31 Jul 2018 12:51

TOP NEWS: Shire Income Up In 2nd-Quarter Ahead Of Takeover By Takeda

LONDON (Alliance News) - Irish biotechnology company Shire PLC on Tuesday posted a more than doubled pretax income in the second quarter, ahead of its upcoming takeover by Takeda Pharmaceutical Co

Read more
31 Jul 2018 12:12

Shire posts 4 pct rise in Q2 earnings ahead of sale to Takeda

LONDON, July 31 (Reuters) - Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to just

Read more
31 Jul 2018 12:08

Shire's quarterly sales rise on immunology demand

(Sharecast News) - Shire reported healthy sales growth in the second quarter as the biotech company pressed ahead with its acquisition by Takeda of Japan.

Read more
31 Jul 2018 08:05

UPDATE 1-Takeda posts weakest Q1 profit in three years

* Q1 operating profit Y98.9 bln vs Y195 bln a year earlier * Takeda booked gains from asset sales a year earlier (Adds details) TOKYO, July 31 (Reuters) - Japan's Takeda Co Ltd a

Read more
25 Jul 2018 07:00

RPT-ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more
24 Jul 2018 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 25 July GlaxoSmithKlineHalf Year Results (at 1200 BST)Vodafone GroupTrading 26

Read more
24 Jul 2018 15:08

ANALYSIS-Buy yen in crisis? Not this year

* Yen weakest G10 currency this month despite global turbulence * Investors doubt BOJ can reduce stimulus aggressively * Japanese purchases of foreign equities highest in nearly Bond

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.